Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07708493
Clinical Trial
A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight
Not Yet Recruiting
Phase 1
View on ClinicalTrials.gov →
Summary
The main objectives of this trial are: To assess the mass balance (total recovery of \[14C\]-radioactivity) in urine, faeces, and expired air after a single subcutaneous dose of BI 3034701 (C-14) in healthy male trial participants.
Trial Details
NCT Number
NCT07708493
Lead Sponsor
Boehringer Ingelheim
Conditions
Healthy
Enrollment
8 participants
Start Date
2026-07-29
Primary Completion
2026-10-14
(estimated)
Study Completion
2026-10-14
(estimated)
Updated on ClinicalTrials.gov
2026-07-16